ATN Medical in Portugal and Tridentify sign distribution agreement - Shelf-Life Management for the cold value chain
ATN Medical in Portugal and Tridentify sign distribution agreement
Tridentify, the Swedish MedTech and SaaS* company that markets and sells the QTA Tracer System®, a unique patented system with automatic Shelf-Life management, has signed a non-exclusive distribution agreement with ATN Medical in Portugal. ATN Medical is a well-established distributor in Portugal and represents several respected brands within the healthcare industry. The QTA Tracer System® enables ATN Medical to expand into transfusion medicine with a special emphasis on blood banks, blood products and transfusion medicine in Portugal.
ATN Medical has a well-established network of sales representatives, clinicians, KOLs and customers in Portugal. The sales activities will start immediately.
”ATN Medical is expanding and is a growing company. ATN Medical is committed and engaged, and has established operations throughout Portugal, from which we will benefit from the first day”. We are excited about the partnership and look forward to close collaboration, says Ann-Christine Jungmar, CEO at Tridentify.
“The unique QTA Tracer System® enables us to expand into transfusion medicine in Portugal. We will benefit from our well-established network and experience of targeting hospitals and the OR, as well as other departments where the need of blood is high.“
“We are a dynamic and innovative company that offers customized solutions that optimize the effectiveness of the healthcare professionals and improve the clinical outcome for patients. Tridentify’s SaaS solution fits perfectly into our strategy of expanding our market share within the area of transfusion medicine in Portugal.”
“The ease-of-use, the fact that the QTA tracers eliminate cold chain uncertainties during handling, storing, and transporting blood products and save lives, are three important factors that make this a compelling opportunity for ATN Medical. We are looking forward to a successful partnership”, Nuno Carvalho, General Manager at ATN Medical Lda., says.
About ATN Medical Lda
ATN Medical Lda., has the distribution rights to other MedTech products such as probes for measure intracranial pressure (ICP), real-time measurements of tissue perfusion (CBF), VP programmable Shunts, EVD (external ventricular drainage), custom made cranial implants that are products used during neurosurgery and more, that target many needs within neurosurgery, Spine surgery and intensive care units.
ATN Medical began its activity in the marketing and distribution of medical devices in 2015, in the areas of Neurosurgery, Spinal surgery and Intensive Care. The portfolio has expanded over the last decade to include medical devices within the field of general surgery and pulmonology.
Regional sales representatives cover the whole Portuguese market. Dedicated service and training professionals ensure both clinical and product training and after-sales support.
About Tridentify AB
Tridentify, a MedTech and Software-as-a-Service* (SaaS) company, based in Sweden, was founded in 2009. Tridentify develops, manufactures, markets and sells the QTA Tracer System®, a unique patented system for automatic Shelf-Life management, across the world.
The system safeguards cold chain logistics with real-time tracking of temperature, light and movement of sensitive medicines, vaccines, blood, plasma, stem cells, biologicals, pharmaceuticals and more.
The combination of the CE-marked and patented system with easy-to-use tracers, shelf-life management and innovative user interface adds value to the healthcare industry by eliminating cold chain uncertainties and enables automatic release.
The main benefits of the QTA Tracer System®, it:
- Eliminates uncertainty
- Increases patient safety
- Streamlines cold chain processes
- Reduces waste
- Saves time and money
Shelf-Life Management, based on stability budget of any biologics or pharma product— Safeguarding as a Service®
* Tridentify has a SaaS solution using a unique IoMT Tracer that is a MDD MedTech Device Class IIa.
MDD Certificate extended to end of 2028 due to Article 120 of MDR.
---------------------------------------------------------------------------------
For more information, please contact:
Ann-Christine Jungmar, CEO Tridentify
ann-christine.jungmar@tridentify.com
Mobile: +46 708714676
Nuno Carvalho, General Manager ATN Medical Lda.
ncarvalho@atnmedical.pt
Mobile: +351 912799525
For more information, please contact:
Ann-Christine Jungmar, CEO Tridentify
ann-christine.jungmar@tridentify.com
Mobile: +46 708714676
Nuno Carvalho, General Manager ATN Medical Lda.
ncarvalho@atnmedical.pt
Mobile: +351 912799525
Tridentify, a MedTech and Software-as-a-Service* (SaaS) company, based in Sweden, was founded in 2009. Tridentify develops, manufactures, markets and sells the QTA Tracer System®, a unique patented system for automatic Shelf-Life management, across the world.
The system safeguards cold chain logistics with real-time tracking of temperature, light and movement of sensitive medicines, vaccines, blood, plasma, stem cells, biologicals, pharmaceuticals and more.
The combination of the CE-marked and patented system with easy-to-use tracers, shelf-life management and innovative user interface adds value to the healthcare industry by eliminating cold chain uncertainties and enables automatic release.
The main benefits of the QTA Tracer System®, it:
- Eliminates uncertainty
- Increases patient safety
- Streamlines cold chain processes
- Reduces waste
- Saves time and money
Shelf-Life Management, based on stability budget of any biologics or pharma product— Safeguarding as a Service®
For more information, visit tridentify.com
Taggar:
